Karachi: Sitara Peroxide Limited has made a disclosure concerning a significant transaction involving its shares, as required under the Pakistan Stock Exchange (PSX) Regulation 5.6.4. The transaction was carried out by one of the company's non-executive directors, Mrs. Sharmeen Imran.

On May 20, 2025, Mrs. Sharmeen Imran, a non-executive director at Sitara Peroxide Limited, executed a purchase of 160,000 shares in the company. The shares were acquired at a rate of 15.50 per share, bringing her cumulative holdings to 3,044,435 shares. This transaction increased Mrs. Imran's cumulative percentage of ownership in the company to 5.53%.

According to information available from the Pakistan Stock Exchange (PSX), the transaction was completed using the Central Depository Company (CDC) system under the Non-Deliverable Market (NDM) category. The PSX, which operates under a designated market category, requires the disclosure of such transactions to maintain transparency and provide stakeholders with timely information.

Sitara Peroxide Limited continues to operate within the guidelines set forth by the PSX, ensuring that all relevant parties remain informed about significant changes in shareholding among its directors and substantial shareholders.